{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:31:32Z","timestamp":1793878292123,"version":"4.7.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Over recent decades, improvements in healthcare have reduced mortality and morbidity rates in many conditions. This has resulted, in part, from the identification of effective interventions in randomised trials, and in conducting such trials, a composite outcome measure (COM) with multiple components will increase event rates, which allows study completion with a smaller sample size. In critical care research, the COM \u201cventilator-free days\u201d (VFD) combines mortality and duration of mechanical ventilation (MV) into a single continuous measure, which can be analysed in a variety of ways. This study investigates the usefulness of Poisson and two-part Poisson models compared to\n                      <jats:italic>t<\/jats:italic>\n                      -distribution for the analysis of VFD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data from four studies (\n                      <jats:italic>ALbuterol for the Treatment of ALI (ALTA)<\/jats:italic>\n                      ,\n                      <jats:italic>Early vs. Delayed Enteral Nutrition (EDEN)<\/jats:italic>\n                      ,\n                      <jats:italic>Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute Lung Injury (ALI) to reduce pulmonary dysfunction (HARP-2)<\/jats:italic>\n                      ,\n                      <jats:italic>Statins for Acutely Injured Lungs from Sepsis (SAILS)<\/jats:italic>\n                      ) were used for analysis, with the VFD results summarised using mean, standard deviation (SD), median, interquartile range (25th and 75th percentiles) and minimum and maximum values. The statistical analyses that are compared used the\n                      <jats:italic>t<\/jats:italic>\n                      -test, Poisson, zero-inflated Poisson (ZIP) and two-part Logit-Poisson hurdle models. The analyses were exploratory in nature, and the significance level for differences in the estimates was set to 0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In HARP-2, which compared simvastatin and placebo, the mean (SD) VFD for all patients was 12.0 (10.2), but this mean value did not represent the data distribution as it falls in a zone between two peaks, with the lowest frequency of occurrence. The mean (SD) VFD after excluding patients who died before day 28 and patients who did not achieve unassisted breathing were 15.9 (8.7) and 18.2 (6.6), respectively. The mean difference (95% CI) between the two groups was 1.1 (95% CI: 0.7 to 2.8;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.20) based on an independent\n                      <jats:italic>t<\/jats:italic>\n                      -test. However, when the two-part hurdle model was used, the simvastatin arm had a significantly higher number of non-zero values compared to the placebo group, which indicated that more patients were alive and free of mechanical ventilation in the simvastatin group. Similarly, in ALTA, this model found that significantly more patients were alive and free of MV in the control group. In EDEN and SAILS, there was no significant difference between the control and intervention groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our analyses show that the\n                      <jats:italic>t<\/jats:italic>\n                      -test and Poisson model are not appropriate for bi-modal data (such as VFD) where there is a large number of zero events. The two-part hurdle model was the most promising approach. There is a need for future research to investigate other analysis techniques, such as two-part quantile regression and to determine the impact on sample size requirements for comparative effectiveness trials.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07190-7","type":"journal-article","created":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T22:02:38Z","timestamp":1678658558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8322-213X","authenticated-orcid":false,"given":"Rejina Mariam","family":"Verghis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronagh","family":"Blackwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"issue":"2","key":"7190_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajog.2006.10.903","volume":"196","author":"S Ross","year":"2007","unstructured":"Ross S. Composite outcomes in randomized clinical trials: arguments for and against. Am J Obstet Gynecol. 2007;196(2):119 (e111-119. e116).","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"7190_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/dom.12226","volume":"16","author":"T Einarson","year":"2014","unstructured":"Einarson T, Garg M, Kaur V, Hemels M. Composite endpoints in trials of type-2 diabetes. Diabetes Obes Metab. 2014;16(6):492\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"7190_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/CCM.0000000000002890","volume":"46","author":"L Bodet-Contentin","year":"2018","unstructured":"Bodet-Contentin L, Frasca D, Tavernier E, Feuillet F, Foucher Y, Giraudeau B. Ventilator-free day outcomes can be misleading. Crit Care Med. 2018;46(3):425\u20139.","journal-title":"Crit Care Med"},{"issue":"1","key":"7190_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1164\/ajrccm.160.1.9807118","volume":"160","author":"GD Rubenfeld","year":"1999","unstructured":"Rubenfeld GD, Angus DC, Pinsky MR, et al. Outcomes research in critical care: results of the American Thoracic Society critical care assembly workshop on outcomes research. Am J Respir Crit Care Med. 1999;160(1):358\u201367.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"7190_CR5","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1097\/00003246-200208000-00016","volume":"30","author":"DA Schoenfeld","year":"2002","unstructured":"Schoenfeld DA, Bernard GR. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30(8):1772\u20137.","journal-title":"Crit Care Med"},{"key":"7190_CR6","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","volume":"371","author":"DF McAuley","year":"2014","unstructured":"McAuley DF, Laffey JG, O\u2019Kane CM, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014;371:1695\u2013703.","journal-title":"N Engl J Med"},{"key":"7190_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/cc2955","volume":"8","author":"V Bewick","year":"2004","unstructured":"Bewick V, Cheek L, Ball J. Statistics review 12: survival analysis. Critical Care-London-. 2004;8:389\u201394.","journal-title":"Critical Care-London-"},{"issue":"7","key":"7190_CR8","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1164\/rccm.201810-2050CP","volume":"200","author":"N Yehya","year":"2019","unstructured":"Yehya N, Harhay MO, Curley MA, Schoenfeld DA, Reeder RW. Reappraisal of ventilator-free days in critical care research. Am J Respir Crit Care Med. 2019;200(7):828\u201336.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"7190_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601\u20139.","journal-title":"Circulation"},{"issue":"21","key":"7190_CR10","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1002\/sim.5798","volume":"32","author":"G Rauch","year":"2013","unstructured":"Rauch G, Beyersmann J. Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework. Stat Med. 2013;32(21):3595\u2013608.","journal-title":"Stat Med"},{"issue":"1","key":"7190_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc3949","volume":"10","author":"D Schoenfeld","year":"2005","unstructured":"Schoenfeld D. Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies. Crit Care. 2005;10(1):1\u20132.","journal-title":"Crit Care"},{"key":"7190_CR12","volume-title":"LOS_model: a simulated hospital length-of-stay dataset","author":"C Mainey","year":"2021","unstructured":"Mainey C. LOS_model: a simulated hospital length-of-stay dataset. 2021. https:\/\/cran.r-project.org\/web\/packages\/NHSRdatasets\/vignettes\/LOS_model.html."},{"key":"7190_CR13","volume-title":"Fitting distribution to given data","author":"S Ye","year":"2015","unstructured":"Ye S. Fitting distribution to given data. 2015. https:\/\/rstudio-pubs-static.s3.amazonaws.com\/116901_909806f789dc4f33b08e92e9d462c1b7.html."},{"key":"7190_CR14","unstructured":"Matange S. CTSPedia clinical graphs - subgrouped forest plot. 2016. https:\/\/blogs.sas.com\/content\/graphicallyspeaking\/2016\/05\/30\/ctspedia-clinical-graphs-subgrouped-forest-plot\/."},{"issue":"1","key":"7190_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/1269547","volume":"34","author":"D Lambert","year":"1992","unstructured":"Lambert D. Zero-inflated Poisson regression, with an application to defects in manufacturing. Technometrics. 1992;34(1):1\u201314.","journal-title":"Technometrics"},{"key":"7190_CR16","unstructured":"Zero Inflated Poisson Regression | R Data Analysis Examples. https:\/\/stats.idre.ucla.edu\/r\/dae\/zip\/."},{"issue":"3","key":"7190_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0304-4076(86)90002-3","volume":"33","author":"J Mullahy","year":"1986","unstructured":"Mullahy J. Specification and testing of some modified count data models. J Econometrics. 1986;33(3):341\u201365.","journal-title":"J Econometrics"},{"issue":"5","key":"7190_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1164\/rccm.201012-2090OC","volume":"184","author":"National Heart L, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network","year":"2011","unstructured":"National Heart L, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Randomized, placebo-controlled clinical trial of an aerosolized \u03b22-agonist for treatment of acute lung injury. Am J Respir Crit Care Med. 2011;184(5):561\u20138.","journal-title":"Am J Respir Crit Care Med."},{"issue":"8","key":"7190_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jama.2012.137","volume":"307","author":"TN Heart","year":"2012","unstructured":"Heart TN. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA. 2012;307(8):795.","journal-title":"JAMA"},{"issue":"23","key":"7190_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","volume":"370","author":"TN Heart","year":"2014","unstructured":"Heart TN. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370(23):2191.","journal-title":"N Engl J Med"},{"issue":"8","key":"7190_CR21","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1164\/rccm.201309-1645PP","volume":"189","author":"B Blackwood","year":"2014","unstructured":"Blackwood B, Clarke M, McAuley DF, McGuigan PJ, Marshall JC, Rose L. How outcomes are defined in clinical trials of mechanically ventilated adults and children. Am J Respir Crit Care Med. 2014;189(8):886\u201393.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"7190_CR22","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1164\/rccm.201308-1499LE","volume":"189","author":"L Contentin","year":"2014","unstructured":"Contentin L, Ehrmann S, Giraudeau B. Heterogeneity in the definition of mechanical ventilation duration and ventilator-free days. Am J Respir Crit Care Med. 2014;189(8):998\u20131002.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"7190_CR23","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1097\/CCM.0000000000003904","volume":"47","author":"B Blackwood","year":"2019","unstructured":"Blackwood B, Ringrow S, Clarke M, et al. A core outcome set for critical care ventilation trials. Crit Care Med. 2019;47(10):1324.","journal-title":"Crit Care Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07190-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07190-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07190-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T22:05:35Z","timestamp":1678658735000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07190-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7190"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07190-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"6 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Northern Ireland Research Ethics Committee, UK, exempted the study from ethical review, but the ethical approval was obtained from the School of Medicine, Dentistry and Biomedical Science, Queens University Belfast, on 10 December 2018 (given that this research was part of RV\u2019s PhD research).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}